Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
2.101
-0.189 (-8.25%)
Nov 21, 2024, 12:55 PM EST - Market open
Calidi Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 41 | 54 | 100 | 282 | - |
| Market Cap Growth | -92.28% | -46.69% | -64.38% | - | - |
| Enterprise Value | 52 | 53 | 121 | - | - |
| Last Close Price | 2.29 | 15.10 | 101.70 | 98.10 | - |
| PS Ratio | - | - | 2232.43 | 628.15 | - |
| PB Ratio | -0.94 | -6.50 | -2.46 | -12.47 | - |
| EV/Sales Ratio | - | - | 2683.59 | - | - |
| Debt / Equity Ratio | -0.92 | -0.88 | -0.15 | -0.23 | -0.87 |
| Asset Turnover | - | - | 0.02 | 0.17 | - |
| Quick Ratio | 0.16 | 0.19 | 0.01 | 0.08 | 0.05 |
| Current Ratio | 0.19 | 0.42 | 0.02 | 0.11 | 0.06 |
| Return on Assets (ROA) | -137.01% | -287.25% | -482.80% | -229.02% | - |
| Earnings Yield | -63.18% | -54.56% | -25.31% | -3.88% | - |
| FCF Yield | -44.17% | -51.48% | -13.58% | -2.83% | - |
| Buyback Yield / Dilution | -402.90% | -98.55% | 56.93% | -15.26% | - |
| Total Shareholder Return | -402.90% | -98.55% | 56.93% | -15.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.